AI in Health Insurance: The Controversy and Its Implications

The recent public spat between billionaire investor Mark Cuban and venture capitalist Marc Andreessen has cast a spotlight on a pressing and often overlooked issue in the healthcare sector: the utilization of artificial intelligence (AI) by health insurers to manage and potentially deny claims. This exchange underlines not just the technological advancements in AI but also raises serious questions about accountability, transparency, and patient rights in a system increasingly reliant on algorithmic decision-making.

The conversation ignited when Andreessen claimed that AI has surpassed human doctors, a statement that echoed sentiments from prominent figures in tech, including Sam Altman, CEO of OpenAI. Their assertions were bolstered by findings from OpenAI's health research lead, suggesting that AI models like GPT-5.6 achieved near-perfect accuracy in approximately 20-25% of cases compared to a mere 10% for human-written responses. Cuban, however, offered a critical counterpoint, emphasizing that while AI may enhance diagnostic capabilities, it fails to address the complexities and frustrations patients encounter when interacting with health insurers post-diagnosis. His remarks resonate deeply, given that the same companies developing sophisticated diagnostic tools are often the ones employing AI to scrutinize claims, which can lead to denials based on algorithmic assessments rather than a thorough human review.

The Growing Role of AI in Health Insurance

According to the National Association of Insurance Commissioners (NAIC), a significant 84% of health insurers are currently leveraging AI or machine learning in some capacity. This includes a troubling trend where approximately 12% specifically apply these technologies to deny prior authorizations for necessary medical procedures. This development raises critical ethical questions about how these algorithms are designed, tested, and implemented in real-world scenarios.

Claims Denial and Litigation Risks

One glaring example of the potential fallout from these practices is the ongoing lawsuit against Cigna, known as Kisting-Leung v. Cigna. This case has attracted attention due to claims that Cigna's algorithm, PxDx, denied over 300,000 claims in just two months during 2022, with an alarming average review time of merely 1.2 seconds per claim. Cigna has characterized the lawsuit as baseless, insisting that PxDx is not AI-driven and only pertains to a limited number of claims. However, a federal judge allowed the case to proceed, indicative of the emerging legal scrutiny surrounding AI in health insurance.

The Impact of AI on Patient Care

As AI systems become more ingrained in the healthcare landscape, the implications for patient care are significant. The Kaiser Family Foundation's analysis of federal marketplace data revealed that fewer than 1% of denied Affordable Care Act claims were appealed in 2023. Among those that were challenged, insurers upheld 56% of the denials, illustrating a claims environment where AI-enabled denial processes operate with limited immediate pushback from patients. This can create an atmosphere of uncertainty and frustration for individuals seeking essential medical care.

Public Trust in AI

Despite the growing prevalence of AI technologies in healthcare, public trust remains low. A recent West Health-Gallup survey found that while one in four U.S. adults had utilized AI for health-related inquiries, only 4% expressed strong confidence in its accuracy. This lack of trust can have far-reaching implications for patient engagement and the overall success of AI integration in healthcare.

Regulatory Responses to AI in Health Insurance

In response to the increasing concerns surrounding AI's role in health insurance, regulatory bodies are stepping up. California's Physicians Make Decisions Act, effective from January 2025, prohibits health insurers from denying medically necessary care solely based on algorithmic assessments. This law mandates that licensed human professionals must review such denials, ensuring that patients receive fair consideration and that their healthcare needs are prioritized.

State-Level Initiatives

Moreover, nearly 30 states have adopted some version of the NAIC's model bulletin on AI governance. The NAIC has introduced the AI Systems Evaluation Tool, which has been piloted in 12 states since March 2026, with a nationwide rollout expected later this year. These initiatives aim to establish a framework for ethical AI use in insurance, addressing concerns about bias and discrimination in algorithmic decision-making.

Challenges Ahead: NAIC and Federal Standoff

Despite these advancements at the state level, the NAIC has expressed concerns over potential federal overreach that could undermine state authority in regulating AI in insurance. Following the White House's December 2025 executive order on AI, the NAIC warned that the order introduces legal uncertainties that may disrupt the insurance market, delay business decisions, and postpone essential consumer protections. The NAIC has called for a clear affirmation of state authority in this domain, emphasizing the importance of maintaining robust governance structures as AI technologies evolve.

Operational Imperatives for Insurers

For health insurers, managing AI governance compliance is not merely an abstract concern; it has become a live operational requirement. With nearly one-third of health insurers failing to routinely test their models for bias, insurers deploying AI in utilization reviews face a dwindling window to document their governance processes before the NAIC's evaluation tool is fully implemented nationwide. This makes it imperative for insurers to prioritize transparency and accountability in their AI applications.

Key Takeaways

• AI is increasingly used by health insurers, with 84% employing it in some capacity.
• Legal challenges are mounting against insurers for AI-driven claims denials, raising ethical concerns.
• Public trust in AI remains low, with only 4% of individuals strongly trusting its accuracy.
• State regulations are evolving to ensure human oversight in AI-driven healthcare decisions.
• Insurers face operational pressures to comply with AI governance standards amidst growing scrutiny.

Frequently Asked Questions

What are the main concerns regarding AI in health insurance?

The primary concerns surrounding AI in health insurance revolve around its potential to deny claims without adequate human oversight, the risk of bias and discrimination in algorithmic decision-making, and the overall transparency of how these systems operate. As AI plays a larger role in managing claims, it is essential for insurers to ensure that these technologies are used ethically and responsibly, prioritizing patient care above all.

How is AI being regulated in the health insurance industry?

AI regulation in the health insurance industry is currently being shaped at both state and federal levels. Various states have enacted laws requiring human review of algorithm-driven denials, while the NAIC is working on guidelines to govern AI use in insurance. The introduction of the AI Systems Evaluation Tool aims to standardize how insurers assess and mitigate bias in their AI models, creating a framework for responsible usage across the industry.

What should consumers know about AI's role in their health insurance claims?

Consumers should be aware that while AI can streamline certain processes in health insurance, it also poses risks, particularly concerning claims denials. It is crucial for patients to understand their rights when claims are denied and to be proactive in appealing these decisions if necessary. Familiarizing themselves with the claims process and knowing how to challenge denials can empower consumers to navigate the complexities of health insurance effectively.

What steps can insurers take to improve AI governance?

Insurers can enhance their AI governance by implementing regular bias testing of their models, ensuring transparency in algorithmic decision-making processes, and prioritizing human oversight in critical healthcare decisions. Additionally, collaborating with regulatory bodies to align practices with evolving standards can help insurers mitigate legal risks while fostering trust among consumers.